Stock Taper 
COMMODORE CAPITAL LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Relay Therapeutics, Inc. | RLAY | 12M | $224.52M |
 Editas Medicine, Inc. | EDIT | 8.89M | $28.8M |
 Amylyx Pharmaceuticals, Inc. | AMLX | 5.65M | $101.47M |
 EyePoint Pharmaceuticals, Inc. | EYPT | 4.6M | $65.78M |
 Enliven Therapeutics, Inc. | ELVN | 3.27M | $166.21M |
 Cogent Biosciences, Inc. | COGT | 3.05M | $118.03M |
 Alkermes plc | ALKS | 3M | $157.19M |
 Tango Therapeutics, Inc. | TNGX | 2.25M | $70.33M |
 Definium Therapeutics, Inc. | DFTX | 2M | $94.08M |
 Tyra Biosciences, Inc. | TYRA | 1.88M | $59.89M |
 LB Pharmaceuticals Inc Common Stock | LBRX | 1.5M | $48.68M |
 Pharvaris N.V. | PHVS | 1.43M | $49.28M |
 Relmada Therapeutics, Inc. | RLMD | 1.43M | $9.86M |
 Celldex Therapeutics, Inc. | CLDX | 1.35M | $50.23M |
 Spyre Therapeutics, Inc. | SYRE | 846.79K | $75.18M |
 Kymera Therapeutics, Inc. | KYMR | 250K | $28.67M |